Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics

London, United Kingdom  All United Kingdom companies → Founded 2012
AI Research Lab Medical Device / Hardware Specialty-Focused AI
Series B — $42.9M

Products

Derm.AI
Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
Dermatology AI
Derm.AI is an AI-powered mobile app and software designed by Fraunhofer-Gesellschaft to accelerate skin cancer diagnoses.

See all 1 product →

About Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on healthcare systems. The technology analyzes dermoscopic images of skin lesions, captured using a smartphone with an approved dermatoscope, to triage cases into malignant, pre-malignant, or benign within milliseconds. This allows for the safe discharge of benign cases, reduces the need for unnecessary biopsies, and fast-tracks high-risk patients to specialists.

DERM is the world’s first autonomous AI legally authorized to make clinical decisions on skin cancer without human oversight, holding both a Class III CE mark under European regulations and a Class IIa UKCA mark. It has demonstrated a 99.8% accuracy rate in ruling out cancer, surpassing the typical 98.9% accuracy of dermatologists. The company primarily partners with national health systems and private insurers, with significant deployment across the UK’s National Health Service (NHS) where it has assessed over 170,000 patients and identified more than 15,500 cancers. This has helped some NHS partners avoid up to 95% of face-to-face urgent referral appointments.

Focus Areas

skin cancer detection artificial intelligence in dermatology teledermatology medical device machine learning computer vision

Business Intelligence

Key InvestorsIntrepid Growth Partners, Tech Nation Group, Arvo Venture Capital, Impact Planet Ventures, Social Tech Trust, Wavemaker Three-Sixty Health, Spex Capital, Nesta Impact Investments, Crista Galli Ventures, Hoxton Ventures, Mustard Seed + Partners
PartnershipsNHS (National Health Service) in over 25 organizations, Bupa, Vitality, Chelsea and Westminster Hospital NHS Foundation Trust, NHS Suffolk, University Hospitals Dorset NHS Foundation Trust, Bridgewater Community Healthcare NHS Foundation Trust, Warrington and Halton Teaching Hospitals NHS Foundation Trust, Bolton NHS Foundation Trust, Together First CIC, Human Bytes
Technologycloud-native, AI as a Medical Device (AIaMD), deep learning algorithms, smartphone-based dermoscopic imaging

What Physicians Need to Know

Skin Cancer Detection & AI in Dermatology
Skin Analytics specializes in AI as a Medical Device (AIaMD) for skin cancer detection, utilizing their DERM software to analyze dermoscopic images of skin lesions. Fraunhofer AICOS has developed Derm.AI, a digital solution combining a mobile application and AI software to make the referral process for skin lesions more efficient and aid in early diagnosis. PALMX APPS LTD offers 'Mole Checker & Scanner: DermAi' for tracking skin changes with AI.
Teledermatology & Medical Devices
Skin Analytics' DERM is deployed in NHS dermatology teams to triage patients, reducing urgent suspected skin cancer referrals and improving patient pathways. Fraunhofer AICOS's Derm.AI solution aims to improve existing teledermatology processes in national health systems by assisting general practitioners with image acquisition and dermatologists with risk prioritization. DERM is a Class III CE-marked AI as a Medical Device, capable of autonomously discharging low-risk cases.
Machine Learning & Computer Vision
Both Skin Analytics and Fraunhofer AICOS leverage machine learning and computer vision techniques. Skin Analytics' DERM uses deep ensemble for the recognition of malignancy. Fraunhofer AICOS's Derm.AI mobile application uses computer vision and machine learning for automatic acquisition of high-quality dermatological images and an AI algorithm for prioritizing cases. Fraunhofer AICOS also has expertise in AI solutions for computer vision, time-series analysis, and natural language processing.
Key Differentiators
Skin Analytics' DERM is the world's first autonomous AI for cancer detection, holding a Class III CE mark, allowing it to make clinical decisions without clinician review for low-risk cases. Fraunhofer AICOS focuses on user-centered design, responsible AI, and cyber-physical systems, developing solutions that integrate AI algorithms into edge devices and address data security and privacy. PALMX APPS LTD emphasizes user-centric mobile applications with elegant design and smart technology, integrating modern technologies like AI, real-time sync, and analytics.
Technology Stack
Skin Analytics' DERM platform processes images using an AI algorithm, often with smartphone-captured dermoscopic images. Fraunhofer AICOS's Derm.AI involves a mobile application (for image acquisition) and AI software for prioritization. Their broader technological competencies include user-centered design, artificial intelligence, and cyber-physical systems, with work in IoT platforms, edge & cloud computing, and secure data processing tools. PALMX APPS LTD utilizes modern frameworks like Flutter and native technologies for cross-platform mobile app development, integrating AI and real-time sync.
Physician Tip

For physicians, Skin Analytics' DERM offers a tool to significantly reduce dermatology waiting times by autonomously triaging low-risk skin lesions, allowing specialists to focus on urgent cases. Fraunhofer AICOS's Derm.AI provides a mobile application to assist general practitioners in acquiring high-quality dermatological images and an AI-powered prioritization system for dermatologists, streamlining the referral process and aiding in early diagnosis. Both aim to enhance diagnostic pathways and improve patient outcomes through efficient AI-powered screening and decision support, while emphasizing that the final diagnosis remains with the specialist.

Fraunhofer AICOS's Derm.AI is designed for integration with existing teledermatology processes within national health services and e-referral systems. Their work also involves integrating known standards (e.g., FHIR, FiWARE) to support the development and deployment of ML/AI algorithms. Skin Analytics' DERM is deployed within NHS urgent suspected skin cancer pathways.

Products by Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics

1 product in the directory

Derm.AI
Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
Dermatology AI
Derm.AI is an AI-powered mobile app and software designed by Fraunhofer-Gesellschaft to accelerate skin cancer diagnoses.

What the Web Says

Skin Analytics, in collaboration with Fraunhofer AICOS, has developed an AI-powered tool called DERM for early skin cancer detection. This tool has received positive attention for its high accuracy and efficiency in assessing potential skin cancers from smartphone photographs. PALMX APPS LTD focuses on language learning and authentication apps, with less public review data available in the context of this collaboration. Fraunhofer AICOS itself is a research institution involved in various AI and human-centered design projects, including healthcare applications. There is limited information available on G2, Glassdoor, Capterra, or Reddit specifically combining all three entities, but Skin Analytics' product, DERM, has been positively reviewed in healthcare contexts. There are general discussions on Reddit about the reliability of reviews on platforms like G2 and Capterra, with some users expressing skepticism due to incentivized reviews.

Overall: Mixed

Strengths

  • Skin Analytics' DERM AI tool boasts a 99.8% accuracy rate in ruling out skin cancer, surpassing dermatologists' 98.9% accuracy.
  • The DERM tool provides quick assessments, with scans taking less than 30 seconds.
  • DERM has received the first regulatory approval for AI to independently make clinical decisions on skin cancer without human oversight.
  • The technology is being integrated into NHS pathways, helping to reduce backlogs and free up dermatology capacity.
  • Fraunhofer AICOS is involved in various innovative projects, including those focused on human-centered design and AI in healthcare.
  • PALMX APPS LTD develops engaging language learning apps and a secure palm-based authentication solution.

Limitations

  • There is a lack of combined reviews for all three entities (Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics) on major review platforms like G2, Glassdoor, and Capterra.
  • Some Reddit discussions indicate skepticism about the authenticity of reviews on platforms like G2 and Capterra due to incentivized review practices.
  • There are general concerns on Reddit about the reliability and potential bias of reviews on major software review platforms.
  • One Reddit user reported consistently receiving generic rejection emails from Fraunhofer-Gesellschaft, indicating a lack of personalized feedback for job applicants.
  • A Reddit discussion about an AI startup in Germany (not directly identified as one of the named companies, but relevant to the AI field) highlighted concerns about inexperienced higher management and delivery issues.
  • The PalmX app by Redrock Biometrics (which shares a similar name with PALMX APPS LTD) has not received enough ratings or reviews to display an overview on the App Store.

Based on reviews from: Evening Standard, FeaturedCustomers, App Store - Apple, Google Play, Skin Analytics Spa, palmx apps ltd, Fraunhofer-Gesellschaft, Reddit, YouTube

Last updated: 2026-09-13

Videos

News, demos, and interviews about Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics →

View all on YouTube

Press & Coverage

Skin Analytics
Skin Analytics raises u00a315 million funding to deliver AI skin cancer detection worldwide
Skin Analytics secured u00a315 million in Series B funding led by Intrepid Growth Partners to expand its AI skin cancer detection technology globally and into new dermatology concerns. This funding follows their EU MDR Class III CE mark approval, making their DERM technology the first legally authorized AI medical device to independently make clinical decisions on skin cancer.
2025-04
Skin Analytics
DERM makes medical history as world's first autonomous skin cancer detection system is approved for clinical decisions in Europe
Skin Analytics' DERM, an autonomous AI skin cancer detection system, received Class III CE mark approval under the European Medical Device Regulation (MDR) 2017/745, making it the world's first legally authorized AI to independently make clinical decisions on skin cancer in Europe. This approval paves the way for DERM's expansion across European healthcare systems facing dermatologist shortages.
2025-02
Skin Analytics
Skin Analytics launches DERM Zero at HLTH Europe 2026
Skin Analytics unveiled DERM Zero at HLTH Europe, the world's first regulated medical device technology approved to autonomously assess skin cancer from a standard smartphone. DERM Zero is CE marked to Class III, the EU's highest medical device classification, and aims to remove barriers to early detection by providing clinical-grade skin cancer assessments without specialist equipment or hospital appointments.
2026-06
Skin Analytics
NICE recommends DERM for early use within the NHS, while further evidence is gathered u2013 Commentary from Neil Daly, Founder and CEO, Skin Analytics
On May 1st, 2025, the National Institute for Health and Care Excellence (NICE) published its Early Value Assessment (EVA) of 'Artificial intelligence (AI) technologies for assessing and triaging skin lesions within the urgent suspected skin cancer pathway', recommending DERM for early use within the NHS.
2025-05
Fraunhofer-Gesellschaft
A mobile app and AI software to speed up skin-cancer diagnoses
Fraunhofer AICOS developed the Derm.AI solution, combining smartphone photos with AI-powered image analysis software to provide a swift, first assessment of potentially dangerous skin changes. This solution aims to accelerate early recognition of skin cancer and improve existing Teledermatology processes in the Portuguese National Health System.
2022-02
Skin Analytics
Skin Analytics Receives NHSX Award for AI-Based Skin Cancer Tool
Skin Analytics received an NHSX award for its AI-based skin cancer tool, DERM, which helps increase dermatology capacity, speed up patient access to care, and decrease backlogs within the NHS. DERM identifies benign skin lesions earlier, redirecting dermatology capacity to patients who need it most.
unknown
Fraunhofer Portugal AICOS
AISYM4MED u2013 Synthetic and Scalable Data Platform for Medical Empowered AI
Fraunhofer Portugal AICOS launched the AISYM4MED project, a platform combining Machine Learning techniques and Synthetic Data Generation to provide quality data for medical research. This project aims to address data privacy and security issues in AI applications for healthcare by using anonymization techniques and rigorous control measures for synthetic data.
2022-12
Fraunhofer Portugal AICOS
Advancing Digital Health: Insights from SIGNO & iNNOVSensing
Fraunhofer Portugal AICOS held a closing event for SIGNO and iNNOVSensing, two projects exploring co-creation in ophthalmology and mental health, reinforcing their commitment to developing human-centered AI solutions. The projects focused on designing AI-powered health technologies that align with diverse stakeholder values and addressing challenges in user research and real-world implementation.
2025-04

Frequently Asked Questions

Fraunhofer AICOS focuses on AI and machine learning for medical image analysis, which can be applied to skin cancer detection. PALMX APPS LTD likely offers mobile health applications, potentially integrating AI for early detection or patient management. Skin Analytics specializes in AI-powered solutions for skin cancer detection, often using computer vision to analyze dermatoscopic images and assess risk.
These companies typically validate their AI algorithms through extensive clinical studies and collaborations with dermatologists to ensure accuracy. Their medical devices are expected to comply with relevant regulatory standards such as CE marking in Europe and FDA clearance in the United States, demonstrating their safety and efficacy.
Many AI-powered dermatology solutions are designed for integration with existing teledermatology platforms and EHR systems to streamline workflows. Companies typically offer technical support, including APIs and SDKs for integration, along with ongoing maintenance and troubleshooting assistance.
Pricing models vary but often include subscription-based services, per-use fees, or tiered pricing based on the volume of analyses or features required. Companies usually offer different options to accommodate solo practitioners, large clinics, and integrated healthcare networks.
Fraunhofer AICOS, as a research organization, frequently partners with academic and medical institutions for research and development. Skin Analytics has established partnerships with healthcare providers and research organizations to validate and deploy their technology. The long-term stability of these companies is often supported by ongoing innovation, successful product adoption, and strategic collaborations within the healthcare AI sector.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AllergoGPT is an evidence-based AI operating system that serves as the “brain” behind the allergoSMART ecosystem, focusing on allergology. It integrates diverse data sources such as botany, weather, nutrition, medical guidelines, clinical experience, and real-world patient behavior to provide transparent and valid insights for patients, physicians, and researchers. The system is designed to structure data, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.